{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T04:34:22Z","timestamp":1767846862663,"version":"3.49.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2009,8,4]],"date-time":"2009-08-04T00:00:00Z","timestamp":1249344000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Radiat Environ Biophys"],"published-print":{"date-parts":[[2009,11]]},"DOI":"10.1007\/s00411-009-0237-9","type":"journal-article","created":{"date-parts":[[2009,8,3]],"date-time":"2009-08-03T07:10:18Z","timestamp":1249283418000},"page":"371-378","source":"Crossref","is-referenced-by-count":9,"title":["Rituximab sensitizes a Burkitt lymphoma cell line to cell killing by X-irradiation"],"prefix":"10.1007","volume":"48","author":[{"given":"Min","family":"Fengling","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liu","family":"Fenju","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen","family":"Wanxin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhai","family":"Lijia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tong","family":"Jiandong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wang","family":"Zu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuan","family":"Xin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gao","family":"Qingxiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,8,4]]},"reference":[{"key":"237_CR1","first-page":"709","volume":"7","author":"S Alas","year":"2001","unstructured":"Alas S, Emmanouilides C, Bonavida B (2001) Inhibition of interleukin 10 by rituximab results in down-regulation of bcl-2 and sensitization of B-cell non-Hodgkin\u2019s lymphoma to apoptosis. Clin Cancer Res 7:709\u2013723","journal-title":"Clin Cancer Res"},{"key":"237_CR2","doi-asserted-by":"crossref","first-page":"2771","DOI":"10.1182\/blood.V98.9.2771","volume":"98","author":"B Bellosillo","year":"2001","unstructured":"Bellosillo B, Villamor N, L\u00f3pez-Guillermo A, Marc\u00e9 S, Esteve J, Campo E, Colomer D, Montserrat E (2001) Complement-mediated cell death induced by rituximab in B-cell lymphoproliferative disorders is mediated in vitro by a caspase-independent mechanism involving the generation of reactive oxygen species. Blood 98:2771\u20132777","journal-title":"Blood"},{"key":"237_CR3","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1023\/A:1008416911099","volume":"9","author":"NL Berinstein","year":"1998","unstructured":"Berinstein NL, Grillo-L\u00f3pez AJ, White CA, Bence-Bruckler I, Maloney D, Czuczman M, Green D, Rosenberg J, McLaughlin P, Shen D (1998) Association of serum Rituximab (IDEC-C2B8) concentration and anti-tumor response in the treatment of recurrent low-grade or follicular non-Hodgkin\u2019s lymphoma. Ann Oncol 9:995\u20131001","journal-title":"Ann Oncol"},{"key":"237_CR4","doi-asserted-by":"crossref","first-page":"111","DOI":"10.2174\/138161206780574588","volume":"12","author":"S Boehrer","year":"2006","unstructured":"Boehrer S, Nowak D, Hoelzer D, Mitrou PS, Chow KU (2006) Novel agents aiming at specific molecular targets increase chemosensitivity and overcome chemoresistance in hematopoietic malignancies. Curr Pharm Des 12:111\u2013128","journal-title":"Curr Pharm Des"},{"key":"237_CR5","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1042\/bss0710097","volume":"71","author":"M Burkitt","year":"2004","unstructured":"Burkitt M, Jones C, Lawrence A, Wardman P (2004) Activation of cytochrome c to a peroxidase compound I-type intermediate by H2O2: relevance to redox signalling in apoptosis. Biochem Soc Symp 71:97\u2013106","journal-title":"Biochem Soc Symp"},{"key":"237_CR6","first-page":"104","volume":"91","author":"C Buske","year":"2006","unstructured":"Buske C, Weigert O, Dreyling M, Unterhalt M, Hiddemann W (2006) Current status and perspective of antibody therapy in follicular lymphoma. Haematologica 91:104\u2013112","journal-title":"Haematologica"},{"key":"237_CR7","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1023\/B:APPT.0000045782.56480.6b","volume":"9","author":"ZG Cui","year":"2004","unstructured":"Cui ZG, Kondo T, Feril LB Jr, Waki K, Inanami O, Kuwabara M (2004) Effects of antioxidants on X-ray- or hyperthermia-induced apoptosis in human lymphoma U937 cells. Apoptosis 9:757\u2013763","journal-title":"Apoptosis"},{"key":"237_CR8","doi-asserted-by":"crossref","first-page":"22632","DOI":"10.1074\/jbc.270.38.22632","volume":"270","author":"JP Deans","year":"1995","unstructured":"Deans JP, Kalt L, Ledbetter JA, Schieven GL, Bolen JB, Johnson P (1995) Association of 75\/80-kDa phosphoproteins and the tyrosine kinases Lyn, Fyn, and Lck with the B cell molecule CD20. Evidence against involvement of the cytoplasmic regions of CD20. J Biol Chem 270:22632\u201322638","journal-title":"J Biol Chem"},{"key":"237_CR9","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1093\/bmb\/ldm025","volume":"83","author":"CE Dearden","year":"2007","unstructured":"Dearden CE (2007) Role of antibody therapy in lymphoid malignancies. Br Med Bull 83:275\u2013290","journal-title":"Br Med Bull"},{"key":"237_CR10","doi-asserted-by":"crossref","first-page":"20828","DOI":"10.1074\/jbc.M211841200","volume":"278","author":"F Esposito","year":"2003","unstructured":"Esposito F, Chirico G, Montesano Gesualdi N, Posadas I, Ammendola R, Russo T, Cirino G, Cimino F (2003) Protein kinase B activation by reactive oxygen species is independent of tyrosine kinase receptor phosphorylation and requires SRC activity. J Biol Chem 278:20828\u201320834","journal-title":"J Biol Chem"},{"key":"237_CR11","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1158\/1078-0432.CCR-06-2082","volume":"13","author":"JP Fruehauf","year":"2007","unstructured":"Fruehauf JP, Meyskens FL Jr (2007) Reactive oxygen species: a breath of life or death? Clin Cancer Res 13:789\u2013794","journal-title":"Clin Cancer Res"},{"key":"237_CR12","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/j.freeradbiomed.2007.10.048","volume":"44","author":"D Gupta","year":"2008","unstructured":"Gupta D, Crosby ME, Almasan A, Macklis RM (2008) Regulation of CD20 expression by radiation-induced changes in intracellular redox status. Free Radic Biol Med 44:614\u2013623","journal-title":"Free Radic Biol Med"},{"key":"237_CR13","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1679\/aohc.65.301","volume":"65","author":"Y Hosokawa","year":"2002","unstructured":"Hosokawa Y, Tanaka L, Kaneko M, Sakakura Y, Tsuruga E, Irie K, Yajima T (2002) Apoptosis induced by generated OH radicals inside cells after irradiation. Arch Histol Cytol 65:301\u2013305","journal-title":"Arch Histol Cytol"},{"key":"237_CR14","doi-asserted-by":"crossref","first-page":"7117","DOI":"10.1158\/0008-5472.CAN-03-3500","volume":"64","author":"AR Jazirehi","year":"2004","unstructured":"Jazirehi AR (2004) Inhibition of the Raf-MEK1\/2-ERK1\/2 signaling pathway, Bcl-xL down-regulation, and chemosensitization of non-Hodgkin\u2019s lymphoma B cells by Rituximab. Cancer Res 64:7117\u20137126","journal-title":"Cancer Res"},{"key":"237_CR15","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1016\/j.freeradbiomed.2004.08.016","volume":"37","author":"VE Kagan","year":"2004","unstructured":"Kagan VE, Borisenko GG, Tyurina YY, Tyurin VA, Jiang J, Potapovich AI, Kini V, Amoscato AA, Fujii Y (2004) Oxidative lipidomics of apoptosis: redox catalytic interactions of cytochrome c with cardiolipin and phosphatidylserine. Free Radic Biol Med 37:1963\u20131985","journal-title":"Free Radic Biol Med"},{"key":"237_CR16","doi-asserted-by":"crossref","first-page":"674","DOI":"10.2967\/jnumed.107.043752","volume":"49","author":"NS Kapadia","year":"2008","unstructured":"Kapadia NS, Engles JM, Wahl RL (2008) In vitro evaluation of radioprotective and radiosensitizing effects of rituximab. J Nucl Med 49:674\u2013678","journal-title":"J Nucl Med"},{"key":"237_CR17","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0027-5107(99)00123-2","volume":"429","author":"R Mustonen","year":"1999","unstructured":"Mustonen R, Bouvier G, Wolber G, St\u00f6hr M, Peschke P, Bartsch H (1999) A comparison of gamma and neutron irradiation on Raji cells: effects on DNA damage, repair, cell cycle distribution and lethality. Mutat Res 429:169\u2013179","journal-title":"Mutat Res"},{"key":"237_CR18","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s00280-002-0557-9","volume":"51","author":"B Pauwels","year":"2003","unstructured":"Pauwels B, Korst AE, de Pooter CM, Pattyn GG, Lambrechts HA, Baay MF, Lardon F, Vermorken JB (2003) Comparison of the sulforhodamine B assay and the clonogenic assay for in vitro chemoradiation studies. Cancer Chemother Pharmacol 51:221\u2013226","journal-title":"Cancer Chemother Pharmacol"},{"key":"237_CR19","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1186\/1471-2407-6-142","volume":"6","author":"B Pauwels","year":"2006","unstructured":"Pauwels B, Korst AE, Pattyn GG, Lambrechts HA, Kamphuis JA, De Pooter CM, Peters GJ, Lardon F, Vermorken JB (2006) The relation between deoxycytidine kinase activity and the radiosensitising effect of gemcitabine in eight different human tumour cell lines. BMC Cancer 6:142","journal-title":"BMC Cancer"},{"key":"237_CR20","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0161-5890(98)00042-X","volume":"35","author":"IJ Popoff","year":"1998","unstructured":"Popoff IJ, Savage JA, Blake J, Johnson P, Deans JP (1998) The association between CD20 and Src-family tyrosine kinases requires an additional factor. Mol Immunol 35:207\u2013214","journal-title":"Mol Immunol"},{"key":"237_CR21","doi-asserted-by":"crossref","first-page":"4013","DOI":"10.1182\/blood-2004-07-2802","volume":"105","author":"AM Ramos","year":"2005","unstructured":"Ramos AM, Fern\u00e1ndez C, Amr\u00e1n D, Sancho P, de Blas E, Aller P (2005) Pharmacologic inhibitors of PI3K\/Akt potentiate the apoptotic action of the antileukemic drug arsenic trioxide via glutathione depletion and increased peroxide accumulation in myeloid leukemia cells. Blood 105:4013\u20134020","journal-title":"Blood"},{"key":"237_CR22","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.ejmp.2008.04.002","volume":"24","author":"AM Risti\u0107-Fira","year":"2008","unstructured":"Risti\u0107-Fira AM, Petrovi\u0107 IM, Kori\u0107anac LB, Valastro LM, Privitera G, Cuttone G (2008) Assessment of the inhibitory effects of different radiation qualities or chemotherapeutic agents on a human melanoma cell line. Phys Med 24:187\u2013195","journal-title":"Phys Med"},{"key":"237_CR23","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1007\/s00280-005-0147-8","volume":"58","author":"C Simoens","year":"2006","unstructured":"Simoens C, Vermorken JB, Korst AE, Pauwels B, De Pooter CM, Pattyn GG, Lambrechts HA, Breillout F, Lardon F (2006) Cell cycle effects of vinflunine, the most recent promising Vinca alkaloid, and its interaction with radiation, in vitro. Cancer Chemother Pharmacol 58:210\u2013218","journal-title":"Cancer Chemother Pharmacol"},{"key":"237_CR24","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1269\/jrr.46.241","volume":"46","author":"I Skvortsova","year":"2005","unstructured":"Skvortsova I, Popper BA, Skvortsov S, Saurer M, Auer T, Moser R, Kamleitner H, Zwierzina H, Lukas P (2005) Pretreatment with rituximab enhances radiosensitivity of non-Hodgkin\u2019s lymphoma cells. J Radiat Res (Tokyo) 46:241\u2013248","journal-title":"J Radiat Res (Tokyo)"},{"key":"237_CR25","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1269\/jrr.47.183","volume":"47","author":"I Skvortsova","year":"2006","unstructured":"Skvortsova I, Skvortsov S, Popper BA, Haidenberger A, Saurer M, Gunkel AR, Zwierzina H, Lukas P (2006) Rituximab enhances radiation-triggered apoptosis in non-Hodgkin\u2019s lymphoma cells via caspase-dependent and -independent mechanisms. J Radiat Res (Tokyo) 47:183\u2013196","journal-title":"J Radiat Res (Tokyo)"},{"key":"237_CR26","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1111\/j.1365-2567.2005.02213.x","volume":"116","author":"TL Unruh","year":"2005","unstructured":"Unruh TL, Li H, Mutch CM, Shariat N, Grigoriou L, Sanyal R, Brown CB, Deans JP (2005) Cholesterol depletion inhibits src family kinase-dependent calcium mobilization and apoptosis induced by rituximab crosslinking. Immunology 116:223\u2013232","journal-title":"Immunology"},{"key":"237_CR27","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1023\/B:CANC.0000031762.91306.b4","volume":"23","author":"GD Wilson","year":"2004","unstructured":"Wilson GD (2004) Radiation and the cell cycle, revisited. Cancer Metastasis Rev 23:209\u2013225","journal-title":"Cancer Metastasis Rev"},{"key":"237_CR28","doi-asserted-by":"crossref","first-page":"4207","DOI":"10.1182\/blood-2005-10-4222","volume":"107","author":"JN Winter","year":"2006","unstructured":"Winter JN, Weller EA, Horning SJ, Krajewska M, Variakojis D, Habermann TM, Fisher RI, Kurtin PJ, Macon WR, Chhanabhai M, Felgar RE, His ED, Medeiros LJ, Weich JK, Reed JC, Gascoyne RD (2006) Prognostic significance of Bcl-6 protein expression in DLBCL treated with CHOP or R-CHOP: a prospective correlative study. Blood 107:4207\u20134213","journal-title":"Blood"},{"key":"237_CR29","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1093\/carcin\/bgg082","volume":"24","author":"JH Woo","year":"2003","unstructured":"Woo JH, Kim YH, Choi YJ, Kim DG, Lee KS, Bae JH, Min DS, Chang JS, Jeong YJ, Lee YH, Park JW, Kwon TK (2003) Molecular mechanisms of curcumin-induced cytotoxicity: induction of apoptosis through generation of reactive oxygen species, down-regulation of Bcl-XL and IAP, the release of cytochrome c and inhibition of Akt. Carcinogenesis 24:1199\u20131208","journal-title":"Carcinogenesis"},{"key":"237_CR30","doi-asserted-by":"crossref","first-page":"23464","DOI":"10.1074\/jbc.271.38.23464","volume":"271","author":"SR Yan","year":"1996","unstructured":"Yan SR, Berton G (1996) Regulation of Src family tyrosine kinase activities in adherent human neutrophils. Evidence that reactive oxygen intermediates produced by adherent neutrophils increase the activity of the p58c-fgr and p53\/56lyn tyrosine kinases. J Biol Chim 271:23464\u201323471","journal-title":"J Biol Chim"},{"key":"237_CR31","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1023\/A:1015331229263","volume":"7","author":"J Yi","year":"2002","unstructured":"Yi J, Gao F, Shi G, Li H, Wang Z, Shi X, Tang X (2002) The inherent cellular level of reactive oxygen species: one of the mechanisms determining apoptotic susceptibility of leukemic cells to arsenic trioxide. Apoptosis 7:209\u2013215","journal-title":"Apoptosis"}],"container-title":["Radiation and Environmental Biophysics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00411-009-0237-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00411-009-0237-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00411-009-0237-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,21]],"date-time":"2020-05-21T04:19:53Z","timestamp":1590034793000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00411-009-0237-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,8,4]]},"references-count":31,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2009,11]]}},"alternative-id":["237"],"URL":"https:\/\/doi.org\/10.1007\/s00411-009-0237-9","relation":{},"ISSN":["0301-634X","1432-2099"],"issn-type":[{"value":"0301-634X","type":"print"},{"value":"1432-2099","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,8,4]]}}}